Coagulation and fibrinolysis-related antigens in plasma and dialysate of CAPD patients

Peritoneal Dialysis International

Volumn 17, Issue 2, 1997, Pages 162-166

  Goedde, Martin ^a   Sitter, Thomas ^a   Schiffl, Helmut ^a   Bechtel, Ulrike ^a   Schramm, Wolfgang ^a   Spannagl, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Intraperitoneal coagulation; Intraperitoneal fibrinolysis; Peritonitis

Indexed keywords

ALBUMIN; ANTITHROMBIN III; BETA 2 MICROGLOBULIN; FIBRIN DEGRADATION PRODUCT; FIBRIN MONOMER; IMMUNOGLOBULIN G; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BACTERIAL PERITONITIS; BLOOD CLOTTING; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSATE; FEMALE; FIBRIN FORMATION; FIBRINOLYSIS; HUMAN; MALE; PERITONEAL CAVITY; PLASMA; PRIORITY JOURNAL;

EID: 0030712197     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089701700211     Document Type: Article

References (22)

1. Gervin AS, Puckett CL, Silver D. Serosal hypofibrinol-ysis. A cause of postoperative adhesions. Am J Surg 1973; 125(1):80-8.
2. Whitaker D, Papadimitriou JM, Walters M. The mesothelium: its fibrinolytic properties. J Pathol 1982; 136(4):291-9.
3. Sitter T, Spannagl M, Schiffl H, Held E, van Hinsbergh VWM, Kooistra T. Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells. Nephrol Dial Transplant 1995; 10:677-83.
4. Ellis H, Harrison W, Hugh TB. The healing of peritoneum under normal and pathological conditions. Br J Surg 1965; 52:471-6.
5. Hau T, Payne WD, Simmons RL. Fibrinolytic activity of the peritoneum during experimental peritonitis. Surg Gynecol Obstet 1979; 148(3):415-18.
6. Raferty AT. Regeneration of peritoneum: a fibrinolytic study. J Anat 1979; 129:1111-21.
7. Thompson JN, Paterson-Brown S, Harbourne T, Whawell SA, Kalodiki E, Dudley HA. Reduced human peritoneal plasminogen activating activity: possible mechanism of adhesion formation. Br J Surg 1989; 76(4):382-4.
8. Vipond MN, Whawell SA, Thompson JN, Dudley HAF. Peritoneal fibrinolytic activity and intra-abdominal adhesions. Lancet 1990; 335:1120-2.
9. Dobbie J, Henderson I, Wilson L. New evidence on the pathogenesis of sclerosing encapsulating peritonitis (SEP) obtained from serial biopsies. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in continuous ambulatory peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1987; 3:138-49.
10. Dobbie J. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12:12-14.
11. Lill H, Spannagl M, Trauner A, et al. A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo. Blood Coagul Fibrinolysis 1993; 4(1):97-102.
12. Teitel JM, Bauer KA, Lau HK, Rosenberg RD. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F1/2 fragment and thrombin-antithrombin complex. Blood 1982; 59(5):1086-97.
13. Jansen J, Reinders J. Fibrinolysis: system and processes. Coron Artery Dis 1992; 3:425-34.
14. Twardowski ZJ. Peritoneal equilibration test. Perit Dial Bull 1987; 7(3):138-47.
15. Lin JJ, Singhal K, Parton L, Cascio C, Patlak C, Stewart CL. Correlation between plasminogen activator inhibitor-1 and peritoneal transport in pediatric CCPD patients. Perit Dial Int 1995; 15:246-51.
16. Gries E, Paar D, Graben N, Bock KD. Intraperitoneal fibrin-formation and its inhibition in CAPD. Clin Nephrol 1986; 26(4):209-12.
17. Dobbie JW. Serositis: comparative analysis of histological findings and pathogenetic mechanisms in nonbacterial serosal inflammation.Perit Dial Int 1993; 13:256-69.
18. Breborowicz A, Rodela H, Oreopoulos DG. Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 1992; 41(5):1280-5.
19. Sagripanti A, Cupisti A, Baicchi U, Ferdeghini M, Morelli E, Barsotti G. Plasma parameters of the prothrombotic state in chronic uremia.Nephron 1993; 63(3):273-8.
20. Sitter T, Toet K, Fricke H, Schiffl H, Held E, Kooistra T. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators. Am J Physiol 1996; 271(5): R1256-63.
21. Suzuki K, Ishizaki M, Hotta O, et al. Usefulness of dialysate fibrin degradation products and lactic dehydrogenase isoenzyme patterns in assessing the clinical course of peritonitis. Perit Dial Int 1994; 14:231-5.
22. Dörr PJ, Brommer EPJ, Dooijewaard G, Vemer HM. Peritoneal fluid and plasma fibrinolytic activity in women with pelvic inflammatory disease. Thromb Haemost 1992; 68(2):102-5.